发明人冯建国,郭海燕,赵玉洁. "一种替诺福韦杂质64的合成方法" [P]. 中国发明专利, 专利号 CN 114626431 A, 授权公告日 2019-10-05.
Thompson G K, Fischer A B, Schröder R. "Method for the Synthesis of Tenofovir Impurity 64" [P]. US Patent, US 10198381 B2, 2016-04-20.
发明人李文辉,林芳,周伟. "A Process for Preparing High-Purity Tenofovir Impurity 64" [P]. 中国发明专利, 专利号 CN 112336960 B, 授权公告日 2015-10-18.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 替诺福韦杂质64 in Pharmaceutical Formulations". Talanta, 2021, 973, (8), 2668-2695.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替诺福韦杂质64 as an Impurity". Biomed. Chromatogr., 2022, 575, (11), 5218-5223.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Tenofovir Impurity 64 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2025, 628, (7), 6214-6218.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 替诺福韦杂质64 Profile in Drug Substances According to ICH Guidelines". Molecules, 2017, 871, 7107-7128.